Sickle Cell Disease: Genetics, Inheritance, and Population Distribution
Pathophysiology
Sickle cell disease (SCD) is an autosomal recessive hemoglobinopathy caused by a point mutation in the HBB gene (β-globin), producing hemoglobin S. Deoxygenated HbS polymerizes, distorting red cells into sickle shapes that occlude microvasculature, causing ischemia, pain, and organ damage.
Inheritance Pattern
- Two carrier parents (HbAS) → 25% affected (HbSS), 50% carriers, 25% unaffected.
- Carrier state (sickle trait) confers malaria resistance.
Epidemiology
Highest prevalence in sub-Saharan Africa, the Mediterranean, Middle East, and India due to historical malaria selection pressure. In the U.S., SCD affects ~100,000 individuals, predominantly of African ancestry.
Early diagnosis (newborn screening), penicillin prophylaxis, hydroxyurea, and comprehensive care have dramatically improved survival.
Genetic Disorders - Related Articles
- Stickler Syndrome: Genetic Basis, Prevalence, and Ethnicity
- Blood Type Inheritance: Why a Child Always Inherits a Biological Blood Type
- Eugenics: Exploring the History, Ethics, and Implications
- Ankyloglossia (Tongue Tie): Diagnosis & Symptoms
- Karyotype Analysis: Understanding Genetic Diseases
- Harlequin Ichthyosis: Severe Genetic Skin Disorder in Newborns
- Understanding the Role of Genetics in Mental Health
